Serveur d'exploration Tocilizumab - Analysis (France)

Index « Auteurs » - entrée « René-Marc Flipo »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
René Westhovens < René-Marc Flipo < Renée Allaart  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
000015 (2020) Jacques Morel [France] ; Marie Locci [France] ; Frédéric Banal [France] ; Bernard Combe [France] ; Grégoire Cormier [France] ; Maxime Dougados [France] ; René-Marc Flipo [France] ; Christian Marcelli [France] ; Thao Pham [France] ; Stéphanie Rist [France] ; Elizabeth Solau Gervais [France] ; Jean Sibilia [France] ; Cédric Lukas [France]Safety of surgery in patients with rheumatoid arthritis treated with tocilizumab: data from the French (REGistry -RoAcTEmra) Regate registry.
000059 (2019) Jean Darloy [France] ; Nicolas Segaud [France] ; Jean-Hugues Salmon [France] ; Jean-Paul Eschard [France] ; Vincent Goëb [France] ; Xavier Deprez [France] ; Marie-Hélène Guyot [France] ; Eric Houvenagel [France] ; Nicolas Lecuyer [France] ; Laurent Marguerie [France] ; Samuel Gally [France] ; David Pau [France] ; Isabelle Idier [France] ; Guy Baudens [France] ; René-Marc Flipo [France]Tocilizumab Effectiveness After Switching from Intravenous to Subcutaneous Route in Patients with Rheumatoid Arthritis: The RoSwitch Study
000218 (2017-11-03) Alain Saraux [France] ; René-Marc Flipo [France] ; Bernard Combe [France] ; Jacques Tebib [France] ; Christelle Baffie [France] ; Isabelle Idier [France] ; Alain Cantagrel [France]Factors influencing the prescription of Tocilizumab alone or in combination with Dmards in rheumatoid arthritis patients in a real life setting. Pooled analysis of 2 observational studies.
000219 (2017-11-03) Jacques-Eric Gottenberg [France] ; Jacques Morel [France] ; Arnaud Constantin [Royaume-Uni] ; Thomas Bardin [France] ; Alain Cantagrel [France] ; Bernard Combe [France] ; Maxime Dougados [France] ; René-Marc Flipo [France] ; Alain Saraux [France] ; Thierry Schaeverbeke [France] ; Jean Sibilia [France] ; Martin Soubrier [France] ; Olivier Vittecoq [France] ; Gabriel Baron [France] ; Elodie Perrodeau [France] ; Philippe Ravaud [France] ; Xavier Mariette [France]Corticosteroid Sparing Effect of Non-TNF Targeted Biologics, Rituximab, Abatacept and Tocilizumab in Common Practice: Data from 3183 Patients Enrolled in the French Society of Rheumatology Registries
000220 (2017-07-14) Jacques Morel [France] ; Arnaud Constantin [France] ; Gabriel Baron [France] ; Emmanuelle Dernis [France] ; René-Marc Flipo [France] ; Stéphanie Rist [France] ; Bernard Combe [France] ; Jacques-Eric Gottenberg [France] ; Thierry Schaeverbeke [France] ; Martin Soubrier [France] ; Olivier Vittecoq [France] ; Maxime Dougados [France] ; Alain Saraux [France] ; Xavier Mariette [France] ; Philippe Ravaud [France] ; Jean Sibilia [France]Risk factors of serious infections in patients with rheumatoid arthritis treated with tocilizumab in the French registry REGATE
000270 (2017) Cynthia Nourisson [France] ; Martin Soubrier [France] ; Aurélien Mulliez [France] ; Athan Baillet [France] ; Thomas Bardin [France] ; Alain Cantagrel [France] ; Bernard Combe [France] ; Maxime Dougados [France] ; René-Marc Flipo [France] ; Thierry Schaeverbeke [France] ; Jean Sibilia [France] ; Olivier Vittecoq [France] ; Philippe Ravaud [France] ; Jacques-Eric Gottenberg [France] ; Xavier Mariette [France] ; Anne Tournadre [France]Impact of gender on the response and tolerance to abatacept in patients with rheumatoid arthritis: results from the ‘ORA’ registry
000276 (2017) René-Marc Flipo [France] ; Jean-Francis Maillefert [France] ; Pascal Chazerain [France] ; Isabelle Idier [France] ; Mathieu Coudert [France] ; Jacques Tebib [France]Factors influencing the use of tocilizumab as monotherapy in patients with rheumatoid arthritis in a real-life setting: results at 1 year of the ACT-SOLO study
000289 (2017) Marie Desplats [France] ; Tristan Pascart [France] ; Germain Jelin [France] ; Laurène Norberciak [France] ; Peggy Philippe [France] ; Eric Houvenagel [France] ; Vincent Goeb [France] ; René-Marc Flipo [France]Are abatacept and tocilizumab intravenous users willing to switch for the subcutaneous route of administration? A questionnaire-based study.
000363 (2016) Tristan Pascart [France, Niger] ; Peggy Philippe [France] ; Elodie Drumez [France] ; Xavier Deprez [France] ; Bernard Cortet [France] ; Alain Duhamel [France] ; Eric Houvenagel [France] ; René-Marc Flipo [France]Comparative efficacy of tocilizumab, abatacept and rituximab after non‐TNF inhibitor failure: results from a multicentre study
000419 (2015) Alice Courties [France] ; Gilles Grateau ; Peggy Philippe ; René-Marc Flipo ; Leonardo Astudillo ; Bérengère Aubry-Rozier ; Isabelle Fabreguet ; Wafki Fahd ; Olivier Fain ; Pascal Guggenbuhl ; Eric Hachulla ; Thomas Papo ; Christophe Richez ; Jean Sibilia ; Jacques Morel ; Francis Berenbaum ; Jérémie SellamAA amyloidosis treated with tocilizumab: case series and updated literature review.
000751 (????) Alain Saraux [France] ; Stéphanie Rouanet [France] ; René-Marc Flipo [France] ; Jean-Cyril Poncet [France] ; Patrice Fardellone [France] ; Pascal Hilliquin [France] ; Isabelle Idier [France] ; Alain Cantagrel [France]Glucocorticoid-sparing in patients suffering from rheumatoid arthritis and treated with tocilizumab: the SPARE-1 study.

List of associated KwdEn.i

Nombre de
documents
Descripteur
4Aged
4Female
4Humans
4Male
4Middle Aged
3Antibodies, Monoclonal, Humanized (therapeutic use)
3Arthritis, Rheumatoid (drug therapy)
2Antibodies, Monoclonal, Humanized (adverse effects)
2Antirheumatic Agents (therapeutic use)
2Retrospective Studies
1
1Abatacept (administration & dosage)
1Abatacept (adverse effects)
1Abatacept (therapeutic use)
1Adult
1Amyloid A amyloidosis
1Amyloidosis (drug therapy)
1Amyloidosis (pathology)
1Antibodies, Monoclonal, Humanized (administration & dosage)
1Antirheumatic Agents (administration & dosage)
1Antirheumatic Agents (adverse effects)
1Arthritis, Rheumatoid (blood)
1Arthritis, Rheumatoid (diagnosis)
1Arthritis, Rheumatoid (immunology)
1Biological Products (adverse effects)
1Biological Products (therapeutic use)
1Biomarkers (blood)
1Blood Sedimentation
1C-Reactive Protein (metabolism)
1Cross-Sectional Studies
1Drug Substitution
1France
1Infusions, Intravenous
1Injections, Subcutaneous
1Patient Preference (statistics & numerical data)
1Prednisone (therapeutic use)
1Prospective Studies
1Rituximab (adverse effects)
1Rituximab (therapeutic use)
1Severity of Illness Index
1Surveys and Questionnaires
1Time Factors
1Treatment Failure
1clinical-practice
1controlled-trial
1corticosteroids
1danish danbio registry
1disease-activity
1eular recommendations
1inadequate response
1inflammation
1interleukin-6
1interleukin-6 receptor inhibition
1modifying antirheumatic drugs
1nephropathy
1prospective follow-up
1registry regate registry
1tocilizumab

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "René-Marc Flipo" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "René-Marc Flipo" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    René-Marc Flipo
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021